Evolving Approaches in the Management of Neuroendocrine Tumor-Associated Carcinoid Syndrome - Episode 4

Management of Carcinoid Syndrome-Related Symptoms

September 20, 2022

Satya (Nanu) Das, MD, MSCI, Jerome Zacks, MD, Rodney Pommier, MD

Dr Satya (Nanu) Das discusses the typical management strategies for carcinoid syndrome-related symptoms, highlighting the use of somatostatin analogs.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Overview of Neuroendocrine Tumors (NETs)

EP. 2: Overview of Carcinoid Syndrome (CS)

EP. 3: Overview of Carcinoid Heart Disease (CHD)

Now Viewing

EP. 4: Management of Carcinoid Syndrome-Related Symptoms

EP. 5: Diagnosis and Management of Somatostatin Analog-Refractory Carcinoid Syndrome

EP. 6: Available Treatment Options for Somatostatin Analog-Refractory Carcinoid Syndrome

EP. 7: Data from the TELEPATH Trial and Real-World Analyses

EP. 8: Prevention, Treatment, and Management of Carcinoid Heart Disease

EP. 9: Unmet Needs for Patients with Neuroendocrine Tumor-Associated Carcinoid Syndrome

EP. 10: Advice for Community Physicians Treating Patients with Neuroendocrine Tumor-Associated Carcinoid Syndrome